337 related articles for article (PubMed ID: 37063836)
1. A close look at current γδ T-cell immunotherapy.
Ma L; Feng Y; Zhou Z
Front Immunol; 2023; 14():1140623. PubMed ID: 37063836
[TBL] [Abstract][Full Text] [Related]
2. γδ T cells: Major advances in basic and clinical research in tumor immunotherapy.
Zhao Y; Dong P; He W; Zhang J; Chen H
Chin Med J (Engl); 2024 Jan; 137(1):21-33. PubMed ID: 37592858
[TBL] [Abstract][Full Text] [Related]
3. γδ T-cell immunotherapy for lung cancer.
Yoshida Y; Nakajima J; Wada H; Kakimi K
Surg Today; 2011 May; 41(5):606-11. PubMed ID: 21533930
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic avenues for γδ T cells in cancer.
Costa GP; Mensurado S; Silva-Santos B
J Immunother Cancer; 2023 Nov; 11(11):. PubMed ID: 38007241
[TBL] [Abstract][Full Text] [Related]
5. γδ cell-based immunotherapy for cancer.
Lo Presti E; Corsale AM; Dieli F; Meraviglia S
Expert Opin Biol Ther; 2019 Sep; 19(9):887-895. PubMed ID: 31220420
[No Abstract] [Full Text] [Related]
6. The Dual Roles of Human γδ T Cells: Anti-Tumor or Tumor-Promoting.
Li Y; Li G; Zhang J; Wu X; Chen X
Front Immunol; 2020; 11():619954. PubMed ID: 33664732
[TBL] [Abstract][Full Text] [Related]
7. γδ T cell exhaustion: Opportunities for intervention.
Chen D; Guo Y; Jiang J; Wu P; Zhang T; Wei Q; Huang J; Wu D
J Leukoc Biol; 2022 Dec; 112(6):1669-1676. PubMed ID: 36000310
[TBL] [Abstract][Full Text] [Related]
8. Targeting γδ T lymphocytes for cancer immunotherapy: from novel mechanistic insight to clinical application.
Gomes AQ; Martins DS; Silva-Santos B
Cancer Res; 2010 Dec; 70(24):10024-7. PubMed ID: 21159627
[TBL] [Abstract][Full Text] [Related]
9. Gamma-delta (γδ) T cells: friend or foe in cancer development?
Zhao Y; Niu C; Cui J
J Transl Med; 2018 Jan; 16(1):3. PubMed ID: 29316940
[TBL] [Abstract][Full Text] [Related]
10. Anti-γδ TCR antibody-expanded γδ T cells: a better choice for the adoptive immunotherapy of lymphoid malignancies.
Zhou J; Kang N; Cui L; Ba D; He W
Cell Mol Immunol; 2012 Jan; 9(1):34-44. PubMed ID: 21666706
[TBL] [Abstract][Full Text] [Related]
11. Gamma Delta T-Cell Based Cancer Immunotherapy: Past-Present-Future.
Saura-Esteller J; de Jong M; King LA; Ensing E; Winograd B; de Gruijl TD; Parren PWHI; van der Vliet HJ
Front Immunol; 2022; 13():915837. PubMed ID: 35784326
[TBL] [Abstract][Full Text] [Related]
12. γδ T cells in cancer immunotherapy.
Zou C; Zhao P; Xiao Z; Han X; Fu F; Fu L
Oncotarget; 2017 Jan; 8(5):8900-8909. PubMed ID: 27823972
[TBL] [Abstract][Full Text] [Related]
13. Cancer immunotherapy harnessing γδ T cells and programmed death-1.
Tanaka Y
Immunol Rev; 2020 Nov; 298(1):237-253. PubMed ID: 32888218
[TBL] [Abstract][Full Text] [Related]
14. γδ T Cells: The Ideal Tool for Cancer Immunotherapy.
Yazdanifar M; Barbarito G; Bertaina A; Airoldi I
Cells; 2020 May; 9(5):. PubMed ID: 32456316
[TBL] [Abstract][Full Text] [Related]
15. The use of BRM-activated killer cells in adoptive immunotherapy: a pilot study with nine advanced cancer patients.
Ebina T; Fujimiya Y; Yamaguchi T; Ogama N; Sasaki H; Isono N; Suzuki Y; Katakura R; Tanaka K; Nagata K; Takano S; Tamura K; Uno K; Kishida T
Biotherapy; 1998; 11(4):241-53. PubMed ID: 9950100
[TBL] [Abstract][Full Text] [Related]
16. Zoledronate facilitates large-scale ex vivo expansion of functional gammadelta T cells from cancer patients for use in adoptive immunotherapy.
Kondo M; Sakuta K; Noguchi A; Ariyoshi N; Sato K; Sato S; Sato K; Hosoi A; Nakajima J; Yoshida Y; Shiraishi K; Nakagawa K; Kakimi K
Cytotherapy; 2008; 10(8):842-56. PubMed ID: 19016372
[TBL] [Abstract][Full Text] [Related]
17. Human gammadelta-T cells in adoptive immunotherapy of malignant and infectious diseases.
Lopez RD
Immunol Res; 2002; 26(1-3):207-21. PubMed ID: 12403359
[TBL] [Abstract][Full Text] [Related]
18. γδ T cells and their clinical application in colon cancer.
Corsale AM; Di Simone M; Lo Presti E; Dieli F; Meraviglia S
Front Immunol; 2023; 14():1098847. PubMed ID: 36793708
[TBL] [Abstract][Full Text] [Related]
19. Anti-tumour immunotherapy with Vγ9Vδ2 T lymphocytes: from the bench to the bedside.
Braza MS; Klein B
Br J Haematol; 2013 Jan; 160(2):123-32. PubMed ID: 23061882
[TBL] [Abstract][Full Text] [Related]
20. Contemplating Dichotomous Nature of Gamma Delta T Cells for Immunotherapy.
Bhat J; Placek K; Faissner S
Front Immunol; 2022; 13():894580. PubMed ID: 35669772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
